Tumori : Impact Factor & More

eISSN: 2038-2529pISSN: 0300-8916

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

Tumori Key Metrics

CiteScore
2.6
H-Index
56
Impact Factor
< 5
SJR
Q3Oncology
SNIP
0.54
Time to Publish
time-to-publish View Chart
5
 Mo

Topics Covered on Tumori

Cancer
Lung cancer
Progression-free survival
Thymoma
Computed tomography
Gastrointestinal tract
Immunotherapy
Overall survival
Postoperative radiotherapy
Extensive-stage small cell lung cancer
Multivariate analysis
Breast cancer
Disease progression
Severe acute respiratory syndrome coronavirus
Adrenalectomy
Hepatocellular carcinoma
Metastatic Lung Adenocarcinoma
Genotype
Osteosarcoma
Maintenance therapy

Tumori Journal Specifications

Overview
Publisher SAGE PUBLICATIONS LTD
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1911
Publisher URLVisit website
Website URLVisit website
View less
NEW

Submissions Pack

Expert Services + AI tools

One subscription packed with expert publication services and AI tools to get you published

Brought to you by
  • Journal Selection Service

    Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.

  • Journal Submission Service

    Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission

Bundle of AI tools for your research needs

Journal Finder, Paperpal, R Discovery, MindTheGraph and more

View benefits in detail

Buy now for a special Launch price!

$199
$249
Time to Publish
% of papers by time taken from submission to publication
0 to 3 months
11%
4 to 6 months
63%
7 to 9 months
20%
Above 9 months
7%

Planning to publish in Tumori ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Compare Similar Journals with Tumori

Select Journals to Compare with Tumori
Total journals - 10
You can select up to 3 Journals at a time

Journal of Clinical Oncology

Publisher: LIPPINCOTT WILLIAMS & WILKINS

Annals of Oncology

Publisher: ELSEVIER

Frontiers in Oncology

Publisher: FRONTIERS MEDIA SA

Cancers

Publisher: MDPI

Medicine

Publisher: Elsevier

BMC Cancer

Publisher: BMC

Cancer Research

Publisher: AMER ASSOC CANCER RESEARCH

European Journal of Cancer

Publisher: ELSEVIER SCI LTD

PLoS ONE

Publisher: PUBLIC LIBRARY SCIENCE

Cancer Management and Research

Publisher: DOVE MEDICAL PRESS LTD
0 Journals Selected to compare with
Tumori
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers

SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers

Get detailed Journal comparison report on your email by signing up

Check if your research matches the topics covered in Tumori?

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Check your research

FAQs on Tumori

How long has Tumori been actively publishing? Faqs

Tumori has been in operation since 1911 till date.

What is the publishing frequency of Tumori? Faqs

Tumori published with a Bi-monthly frequency.

How many articles did Tumori publish last year? Faqs

In 2023, Tumori publsihed 2 articles.

What is the eISSN & pISSN for Tumori? Faqs

For Tumori, eISSN is 2038-2529 and pISSN is 0300-8916.

What is Citescore for Tumori? Faqs

Citescore for Tumori is 2.6.

What is the H Index for Tumori ? Faqs

H Index for Tumori is 56.

What is SNIP score for Tumori? Faqs

SNIP score for Tumori is 0.54.

What is the SJR for Tumori? Faqs

SJR for Tumori is Q3.

Who is the publisher of Tumori? Faqs

SAGE PUBLICATIONS LTD is the publisher of Tumori.